Personalizing dermatology: The future of genomic expression profiling to individualize dermatologic therapy

Amilcar Ezequiel Rizzo, Howard I. Maibach

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

At the start of the 21st century, the human genome project provided the scientific community with an enormous array of information as genetic blueprints. A landmark period, yet its potential contribution to medicine at the time was limited and unknown. However, with new technological advances, the benefits of identifying genomic profiles became apparent. This article reviews the historical accomplishments made by the human genome project, future applications of genomic expression profiles with the use of microarray gene chip technology, and the pharmacogenomic translational application of these models to dermatology. A new scientific movement in dermatology has begun with intentions of discovering individual genomic profiles responsible for dermatologic disease and drug metabolism, so that medical management can be personalized towards the genome rather than the disease. This review shows how pharmacogenomics has taken the lead in forming a basic framework of revealing specific drug metabolic pathways in the skin that can consequently be altered to maximize and minimize therapeutic efficacy and side effects, respectively. Dermatology as a model field in medicine has started to take advantage of these discoveries upon which deciphering genetic profiles can be used to enhance medical treatment.

Original languageEnglish (US)
Pages (from-to)161-167
Number of pages7
JournalJournal of Dermatological Treatment
Volume23
Issue number3
DOIs
StatePublished - Jun 2012

Fingerprint

Dermatology
Human Genome Project
Pharmacogenetics
Medicine
Metabolic Networks and Pathways
Oligonucleotide Array Sequence Analysis
Pharmaceutical Preparations
Therapeutics
Genome
Technology
Skin

Keywords

  • Anti-aging
  • Microarray
  • Pharmacogenomics
  • Skin care

ASJC Scopus subject areas

  • Dermatology

Cite this

Personalizing dermatology : The future of genomic expression profiling to individualize dermatologic therapy. / Rizzo, Amilcar Ezequiel; Maibach, Howard I.

In: Journal of Dermatological Treatment, Vol. 23, No. 3, 06.2012, p. 161-167.

Research output: Contribution to journalArticle

@article{2aa317a3e61d4164b705c4d02ebba30c,
title = "Personalizing dermatology: The future of genomic expression profiling to individualize dermatologic therapy",
abstract = "At the start of the 21st century, the human genome project provided the scientific community with an enormous array of information as genetic blueprints. A landmark period, yet its potential contribution to medicine at the time was limited and unknown. However, with new technological advances, the benefits of identifying genomic profiles became apparent. This article reviews the historical accomplishments made by the human genome project, future applications of genomic expression profiles with the use of microarray gene chip technology, and the pharmacogenomic translational application of these models to dermatology. A new scientific movement in dermatology has begun with intentions of discovering individual genomic profiles responsible for dermatologic disease and drug metabolism, so that medical management can be personalized towards the genome rather than the disease. This review shows how pharmacogenomics has taken the lead in forming a basic framework of revealing specific drug metabolic pathways in the skin that can consequently be altered to maximize and minimize therapeutic efficacy and side effects, respectively. Dermatology as a model field in medicine has started to take advantage of these discoveries upon which deciphering genetic profiles can be used to enhance medical treatment.",
keywords = "Anti-aging, Microarray, Pharmacogenomics, Skin care",
author = "Rizzo, {Amilcar Ezequiel} and Maibach, {Howard I.}",
year = "2012",
month = "6",
doi = "10.3109/09546634.2010.535806",
language = "English (US)",
volume = "23",
pages = "161--167",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Personalizing dermatology

T2 - The future of genomic expression profiling to individualize dermatologic therapy

AU - Rizzo, Amilcar Ezequiel

AU - Maibach, Howard I.

PY - 2012/6

Y1 - 2012/6

N2 - At the start of the 21st century, the human genome project provided the scientific community with an enormous array of information as genetic blueprints. A landmark period, yet its potential contribution to medicine at the time was limited and unknown. However, with new technological advances, the benefits of identifying genomic profiles became apparent. This article reviews the historical accomplishments made by the human genome project, future applications of genomic expression profiles with the use of microarray gene chip technology, and the pharmacogenomic translational application of these models to dermatology. A new scientific movement in dermatology has begun with intentions of discovering individual genomic profiles responsible for dermatologic disease and drug metabolism, so that medical management can be personalized towards the genome rather than the disease. This review shows how pharmacogenomics has taken the lead in forming a basic framework of revealing specific drug metabolic pathways in the skin that can consequently be altered to maximize and minimize therapeutic efficacy and side effects, respectively. Dermatology as a model field in medicine has started to take advantage of these discoveries upon which deciphering genetic profiles can be used to enhance medical treatment.

AB - At the start of the 21st century, the human genome project provided the scientific community with an enormous array of information as genetic blueprints. A landmark period, yet its potential contribution to medicine at the time was limited and unknown. However, with new technological advances, the benefits of identifying genomic profiles became apparent. This article reviews the historical accomplishments made by the human genome project, future applications of genomic expression profiles with the use of microarray gene chip technology, and the pharmacogenomic translational application of these models to dermatology. A new scientific movement in dermatology has begun with intentions of discovering individual genomic profiles responsible for dermatologic disease and drug metabolism, so that medical management can be personalized towards the genome rather than the disease. This review shows how pharmacogenomics has taken the lead in forming a basic framework of revealing specific drug metabolic pathways in the skin that can consequently be altered to maximize and minimize therapeutic efficacy and side effects, respectively. Dermatology as a model field in medicine has started to take advantage of these discoveries upon which deciphering genetic profiles can be used to enhance medical treatment.

KW - Anti-aging

KW - Microarray

KW - Pharmacogenomics

KW - Skin care

UR - http://www.scopus.com/inward/record.url?scp=84861041361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861041361&partnerID=8YFLogxK

U2 - 10.3109/09546634.2010.535806

DO - 10.3109/09546634.2010.535806

M3 - Article

C2 - 21254882

AN - SCOPUS:84861041361

VL - 23

SP - 161

EP - 167

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 3

ER -